查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004990

即时检测与快速诊断市场：2026-2032年全球市场预测（按产品类型、技术、检测类型、最终用户、应用和分销管道划分）

Point of Care & Rapid Diagnostics Market by Product Type, Technology, Test Type, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，即时检测和快速诊断市场价值将达到 556.1 亿美元，到 2026 年将成长至 599.6 亿美元，到 2032 年将达到 912.1 亿美元，年复合成长率为 7.32%。

主要市场统计数据
基准年 2025 556.1亿美元
预计年份：2026年 599.6亿美元
预测年份 2032 912.1亿美元
复合年增长率 (%) 7.32%

观点清楚地反映了快速诊断正在分散检测工作流程，并重新定义所有医疗保健机构中临床决策的时间轴这一现实。

照护现场和快速诊断正在重塑临床工作流程，使患者能够更方便地获得可操作的检测结果，并加快临床决策週期。试剂化学、小型化分析仪、高效能读数器和资料管理软体的进步，使得在门诊中心、诊所、居家照护机构和医院等场所进行分散式检查成为可能。随着仪器操作日益便捷、连接性不断提升，临床医生能够更早介入并更有效地进行分诊，从而改变患者的诊疗路径和资源分配。

市场动态受技术融合、监管演变和医疗服务模式变革的影响。

目前情况是多种因素共同作用的结果，这些因素正在改变诊断检测的地点和方式。分子诊断、免疫检测和小型临床化学平台的技术进步，使得在较小的面积内实现高分析性能成为可能。同时，数据管理软体正从孤立的数据收集转向整合解决方案，从而促进与电子健康记录和远端医疗平台的互通性。监管机构也在调整核准流程，以便更好地适应新的即时检测技术。如果製造商能够满足品质和检验要求，则可以缩短临床部署时间。

分析近期美国关税措施对诊断生态系中的供应链、筹资策略和创新所产生的累积影响。

关税政策的变化正在为全球诊断组件、试剂和成品仪器的供应链带来明显的摩擦。依赖跨境采购分析仪器、读数器、试剂或关键电子元件的製造商正在调整其供应商组合和生产地点以降低风险。这种调整促使企业采取短期成本控制措施和策略采购策略，采购团队专注于供应商多元化和合约柔软性，以应对成本波动和物流延误。

提供实用的细分见解，突显跨产品类型、技术和最终用户环境的需求推动要素和商业化重点。

从产品类型观点来看，耗材、仪器和软体/服务有不同的需求。对于耗材，例如试剂和检测套组，批间一致性、稳定的保质期和供应链的连续性至关重要。对于仪器，例如分析仪器和读数器，稳健性、运转率和易于维护是优先考虑的因素。另一方面，资料管理软体和支援服务需要具备安全的互通性、分析能力和扩充性的服务合约。按技术领域划分，例如临床化学、血液学、免疫检测和分子诊断，可以突出检验流程和用户期望的差异，其中分子诊断方法在病原体检测和高灵敏度检测方面特别引人注目。

在不同医疗保健系统和市场环境下实施即时护理解决方案的区域趋势和实际考虑因素。

在美洲，集中式检查室网路与门诊和家庭环境中不断扩展的即时检测部署相结合，为与电子健康记录整合并实现远端监测的技术创造了机会。在欧洲和中东及非洲，由于报销系统和基础设施成熟度的差异，进展不相同。在某些市场，快速诊断正被纳入国家筛检和公共卫生倡议，而在其他市场，则更注重集中式检查室的整合。在亚太地区，对分散式医疗路径的投资、不断增加的慢性病管理项目以及加速产品在地化的竞争性製造业基地，都在推动成长。

竞争格局分析，重点在于产品系列、服务提案和伙伴关係模式。

即时检测和快速诊断领域的主要企业正透过整合模组化分析仪、耗材生态系统和云端资料平台的整合解决方案来脱颖而出。产品系列将可靠的试剂、灵活的检测套组以及注重运作的仪器相结合，为检查室和医院系统创造了极具吸引力的价值。同样，投资于资料管理软体和全面支援服务的机构，透过确保产品在整个生命週期内的连接性、合规性和可维护性，降低了部署门槛。

为行业领导者提供切实可行的、高优先级的建议，以加速采用新技术、保护利润率并确保商业的未来。

製造商应优先考虑模组化设备架构，以便于组件更换和简化维护，从而减轻供应链中断对营运的影响。同时，投资于支援互通性和远端诊断的资料管理软体，将增强临床医生的信心，并支援基于服务的收入模式。从商业性角度来看，将定价和报销策略与临床结果和医疗保健总成本相结合，将有助于医院网路和门诊管道的推广应用。

采用严谨的调查方法和资料整合方法，以产生可重复的见解并检验结论。

本研究整合了定性和定量证据，以深入了解市场动态。主要资讯来源包括对医院、诊断检查室、门诊中心和居家照护机构的临床决策者、采购经理和产品经理进行的结构化访谈。二级资讯来源包括同行评审文献、监管指南和企业披露信息，以全面检验技术趋势、检验要求和经营模式。

对于希望了解即时诊断趋势的决策者而言，本书整合了策略见解并明确了优先事项。

快速诊断生态系统正处于技术进步、医疗服务模式演变和政策环境变化交汇的十字路口。决策者必须优先考虑硬体、耗材和软体的整合，以确保在供应链和贸易趋势变化的情况下，提供持续的临床价值并维持营运韧性。同样重要的是，要使商业化策略与终端使用者的工作流程、报销实际情况以及当地医疗系统的特征相契合。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 即时诊断与快速诊断市场：按产品类型划分

  • 消耗品
    • 试剂
    • 检测套组
  • 装置
    • 分析器
    • 领导者
  • 软体服务
    • 资料管理软体
    • 支援服务

第九章 即时诊断与快速诊断市场：按技术划分

  • 临床化学
  • 血液学
  • 免疫检测
  • 分子诊断

第十章 按检测类型分類的即时检测和快速诊断市场

  • 心臟标记物
  • 凝血
  • 血糖监测
  • 感染疾病
  • 怀孕与不孕

第十一章 即时诊断与快速诊断市场：按最终用户划分

  • 门诊部
  • 诊所
  • 检查室
  • 居家照护设施
  • 医院

第十二章 即时诊断与快速诊断市场：按应用划分

  • 心臟护理
  • 血液凝固检验
  • 糖尿病管理
  • 感染疾病诊断
  • 肿瘤学
  • 妊娠测试

第十三章 即时诊断与快速诊断市场：按分销管道划分

  • 在线的
  • 离线

第十四章 即时检测与快速诊断市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 即时诊断与快速诊断市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 即时诊断与快速诊断市场：按国家/地区划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国即时检测与快速诊断市场

第十八章：中国的即时侦测与快速诊断市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abaxis, Inc.
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Boditech Med Inc.
  • Chembio Diagnostics, Inc.
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • ELITechGroup SAS
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • QuidelOrtho Corporation
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
Product Code: MRR-742BD5183A2E

The Point of Care & Rapid Diagnostics Market was valued at USD 55.61 billion in 2025 and is projected to grow to USD 59.96 billion in 2026, with a CAGR of 7.32%, reaching USD 91.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 55.61 billion
Estimated Year [2026] USD 59.96 billion
Forecast Year [2032] USD 91.21 billion
CAGR (%) 7.32%

A clear-eyed orientation to how rapid diagnostics are decentralizing testing workflows and redefining clinical decision timelines across care settings

Point of care and rapid diagnostics are reshaping clinical workflows by delivering actionable results closer to patients and accelerating clinical decision cycles. Advances in reagent chemistry, miniaturized analyzers, robust readers, and data management software are enabling decentralized testing across ambulatory care centers, clinics, home care settings, and hospitals. As devices become easier to operate and connectivity improves, clinicians are better positioned to intervene earlier and to triage care more effectively, which in turn alters patient pathways and resource allocation.

Furthermore, as stakeholders increasingly prioritize value-based outcomes, diagnostics that deliver rapid, reliable, and actionable data are gaining practical priority. Laboratories and diagnostic networks are balancing central testing capacity with point of care capabilities to maintain quality while improving speed. Meanwhile, manufacturers are investing in integrated software and support services to ensure interoperability and to reduce total cost of ownership across installed bases. This intersection of technological progress, shifting care models, and rising expectations for timely results is creating a dynamic environment where clinical benefits, reimbursement pathways, and commercial execution must align for success

Transformative shifts in market dynamics driven by technological convergence, regulatory evolution, and changing care delivery models

The landscape is experiencing several converging drivers that are transforming where and how diagnostic testing occurs. Technological progress in molecular diagnostics, immunoassays, and compact clinical chemistry platforms is enabling higher analytical performance in smaller footprints. At the same time, data management software is moving from siloed data capture to integrated solutions that facilitate interoperability with electronic health records and telehealth platforms. Regulatory agencies are also adapting pathways to better accommodate novel point of care technologies, which reduces time to clinical adoption when manufacturers can meet quality and validation expectations.

Concurrently, the shift toward outpatient care and home-based monitoring is prompting manufacturers to re-evaluate form factors, ease of use, and channel strategies. Distribution channels that include direct sales, distributors, e-commerce platforms, and online retail are being optimized to reach new end users while maintaining post-market support through enhanced service models. As stakeholders adapt, market participants that invest in modular instrument architectures, scalable reagent systems, and cloud-enabled analytics will be better positioned to capture demand across cardiac care, diabetes management, infectious disease diagnostics, and oncology applications. In short, the next phase will reward cross-disciplinary integration that connects hardware, consumables, and software into user-centric solutions

Analysis of cumulative impacts from recent United States tariff actions on supply chains, procurement strategies, and innovation within the diagnostics ecosystem

Tariff policy shifts have introduced measurable friction into global supply chains for diagnostics components, reagents, and finished instruments. Manufacturers that rely on cross-border sourcing for analyzers, readers, reagents, or critical electronic components have adjusted supplier portfolios and production footprints to mitigate exposure. This rebalancing has driven near-term cost management activity and strategic sourcing efforts, with procurement teams focusing on supplier diversification and contractual flexibility to absorb cost volatility and logistical delays.

In addition, tariffs have influenced decisions about local assembly and regional manufacturing presence as companies evaluate the tradeoffs between incremental production costs and the benefits of supply resilience. For purchasers in hospitals, clinics, and diagnostic laboratories, procurement cycles are lengthening as stakeholders seek clarity around landed costs and service agreements. Meanwhile, suppliers are accelerating investments in automation and quality control to offset higher per-unit costs and to preserve margins without compromising product performance.

Looking forward, firms that proactively redesign sourcing strategies, prioritize modularity in instrument design to leverage interchangeable components, and strengthen strategic partnerships across distribution channels will reduce tariff-driven exposure. Equally important, regulatory and reimbursement stakeholders will need to consider the cumulative effect of these commercial responses on access and on the pace of innovation in high-impact areas such as molecular and immunoassay testing

Actionable segmentation insights that highlight demand drivers and commercialization priorities across product categories, technologies, and end-user settings

A product-type lens reveals distinct imperatives for consumables, instruments, and software & services. Consumables, including reagents and test kits, emphasize lot-to-lot consistency, shelf-life stability, and supply-chain continuity; instruments, spanning analyzers and readers, prioritize robustness, uptime, and ease of maintenance; while data management software and support services require secure interoperability, analytics capability, and scalable service contracts. Technology segmentation across clinical chemistry, hematology, immunoassay, and molecular diagnostics highlights divergent validation pathways and user expectations, with molecular approaches commanding particular attention for pathogen detection and high-sensitivity assays.

When examining test types such as cardiac markers, coagulation, glucose monitoring, infectious diseases, and pregnancy & fertility panels, commercialization strategies must align with clinical pathways and reimbursement realities to support clinician adoption. End-user segmentation emphasizes that ambulatory care centers and clinics prioritize rapid turnaround and portability, diagnostic laboratories focus on throughput and centralization, home care settings demand simplicity and remote data integration, and hospitals require integration into complex IT ecosystems. Application-focused strategies for cardiac care, coagulation testing, diabetes management, infectious disease diagnostics, oncology, and pregnancy testing must balance analytical rigor with user-centric design. Finally, distribution channel choices-direct sales, distributors, e-commerce platforms, and online retail-shape pricing, warranty models, and post-sale support, making channel strategy a core determinant of market reach and customer satisfaction

Regional dynamics and practical considerations for deploying point of care solutions across diverse healthcare systems and market environments

The Americas exhibit a heterogeneous mix of centralized laboratory networks and expanding point of care deployment in outpatient and home settings, which creates opportunities for technologies that integrate with electronic health records and enable remote monitoring. Across Europe, Middle East & Africa, differences in reimbursement structures and infrastructure maturity drive variable adoption curves; in some markets rapid diagnostics are being adopted as part of national screening and public health initiatives, whereas others emphasize centralized laboratory consolidation. In Asia-Pacific, growth is supported by investments in decentralized care pathways, rising chronic disease management programs, and a competitive manufacturing base that accelerates product localization.

Across all regions, regulatory alignment, reimbursement clarity, and supply chain resilience remain critical determinants of successful commercialization. Localized training and support models, tailored pricing strategies, and partnerships with clinical networks facilitate adoption. Moreover, interoperability with regional health information exchanges and telemedicine platforms enhances the clinical value proposition. Ultimately, companies that marry global best practices with local execution capabilities will unlock meaningful adoption across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Competitive landscape insights focusing on product portfolios, service propositions, and partnership models that shape market positioning

Leading companies in the point of care and rapid diagnostics space are differentiating through integrated solutions that pair modular analyzers with consumable ecosystems and cloud-enabled data platforms. Product portfolios that combine reliable reagents and adaptable test kits with instruments engineered for uptime create compelling value for diagnostic laboratories and hospital systems. Equally, organizations that invest in data management software and comprehensive support services reduce adoption friction by ensuring connectivity, compliance, and lifecycle serviceability.

Partnership models are shifting toward co-development agreements with clinical institutions and technology providers to accelerate validation and to generate real-world evidence. Distribution strategies that blend direct sales with distributor partnerships and digital channels are enabling broader market reach while preserving local service capabilities. Competitive advantage increasingly depends on the ability to demonstrate outcomes, to reduce total cost of ownership, and to provide integrated post-sale support. Companies that align product development with clinician workflows and that leverage partnerships to deliver end-to-end solutions will maintain stronger positioning in a market where performance, service excellence, and interoperability determine buyer preference

Practical and prioritized recommendations for industry leaders to accelerate adoption, protect margins, and future-proof their operations

Manufacturers should prioritize modular instrument architectures that allow for component substitution and simplify servicing, thereby reducing the operational impact of supply chain disruptions. In parallel, investing in data management software that supports interoperability and remote diagnostics will enhance clinician trust and enable service-based revenue models. From a commercial perspective, aligning pricing and reimbursement strategies with clinical outcomes and total cost of care will facilitate adoption in both hospital networks and ambulatory channels.

Operationally, companies must strengthen multi-sourcing strategies, consider regional manufacturing partnerships to mitigate tariff exposure, and implement agile inventory management practices. Strategic collaborations with clinical sites for early validation and real-world evidence generation will accelerate payer engagement and clinician uptake. Finally, forging flexible distribution approaches that combine direct sales, careful distributor selection, and digital commerce will expand reach while preserving post-sale service standards. Taken together, these actions will help leaders maximize impact, sustain margins, and remain nimble in an environment characterized by rapid technological change and evolving care delivery models

Rigorous research methodology and data synthesis approach used to produce reproducible insights and validate conclusions

The research process integrated qualitative and quantitative evidence streams to create a robust understanding of market dynamics. Primary inputs included structured interviews with clinical decision-makers, procurement leaders, and product managers across hospitals, diagnostic laboratories, ambulatory care centers, and home care providers. Secondary sources encompassed peer-reviewed literature, regulatory guidance, and company disclosures to triangulate technology trends, validation requirements, and commercial models.

Data synthesis applied thematic analysis to capture common adoption barriers and enablement factors, while comparative case studies highlighted successful deployment models across different regions. Throughout, methodological safeguards ensured that conclusions relied on validated expert perspectives and documented performance characteristics rather than speculative forecasts. The approach prioritized transparency in assumptions and documented limitations to allow readers to interpret findings within the appropriate operational context. This methodological rigor produces actionable insights that are reproducible and applicable to strategy formulation, product development, and commercial planning

Concluding perspectives that synthesize strategic implications and reinforce priorities for decision-makers navigating the point of care diagnostics landscape

The rapid diagnostics ecosystem is at an inflection point where technological advances intersect with shifting care delivery models and evolving policy environments. Decision-makers must prioritize integration across hardware, consumables, and software to deliver consistent clinical value while maintaining operational resilience in the face of supply chain and trade dynamics. Equally important is the alignment of commercialization strategies with end-user workflows, reimbursement realities, and regional healthcare system characteristics.

Looking ahead, success will favor organizations that combine product excellence with robust service and data strategies, that invest in regional operational flexibility, and that cultivate partnerships to accelerate validation and adoption. By concentrating on modularity, interoperability, and outcomes-driven evidence generation, stakeholders can translate diagnostic innovations into measurable improvements in patient care. In sum, the pathway to sustainable growth rests on disciplined execution that bridges technical capability with pragmatic market implementation

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Point of Care & Rapid Diagnostics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Reagents
    • 8.1.2. Test Kits
  • 8.2. Instruments
    • 8.2.1. Analyzers
    • 8.2.2. Readers
  • 8.3. Software & Services
    • 8.3.1. Data Management Software
    • 8.3.2. Support Services

9. Point of Care & Rapid Diagnostics Market, by Technology

  • 9.1. Clinical Chemistry
  • 9.2. Hematology
  • 9.3. Immunoassay
  • 9.4. Molecular Diagnostics

10. Point of Care & Rapid Diagnostics Market, by Test Type

  • 10.1. Cardiac Markers
  • 10.2. Coagulation
  • 10.3. Glucose Monitoring
  • 10.4. Infectious Diseases
  • 10.5. Pregnancy & Fertility

11. Point of Care & Rapid Diagnostics Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Home Care Settings
  • 11.5. Hospitals

12. Point of Care & Rapid Diagnostics Market, by Application

  • 12.1. Cardiac Care
  • 12.2. Coagulation Testing
  • 12.3. Diabetes Management
  • 12.4. Infectious Disease Diagnostics
  • 12.5. Oncology
  • 12.6. Pregnancy Testing

13. Point of Care & Rapid Diagnostics Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Point of Care & Rapid Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Point of Care & Rapid Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Point of Care & Rapid Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Point of Care & Rapid Diagnostics Market

18. China Point of Care & Rapid Diagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abaxis, Inc.
  • 19.6. Abbott Laboratories
  • 19.7. AccuBioTech Co., Ltd.
  • 19.8. Becton, Dickinson and Company
  • 19.9. bioMerieux SA
  • 19.10. Boditech Med Inc.
  • 19.11. Chembio Diagnostics, Inc.
  • 19.12. Danaher Corporation
  • 19.13. Eiken Chemical Co., Ltd.
  • 19.14. ELITechGroup SAS
  • 19.15. F. Hoffmann-La Roche Ltd.
  • 19.16. Meridian Bioscience, Inc.
  • 19.17. OraSure Technologies, Inc.
  • 19.18. QuidelOrtho Corporation
  • 19.19. Sekisui Diagnostics, LLC
  • 19.20. Siemens Healthineers AG
  • 19.21. Sysmex Corporation
  • 19.22. Thermo Fisher Scientific Inc.
  • 19.23. Trinity Biotech plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 199. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 231. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)